Veriti Management LLC Bausch Health Companies Inc. Transaction History

Veriti Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 20, 2023	BUY	$6.09 - $7.93 $72,343 - $94,200	11,879 New	11,879 $0
Q3 2021 Oct 08, 2021	SELL	$25.04 - $30.06 $239,482 - $287,493	-9,564 Closed	0 $0
Q2 2021 Jul 13, 2021	BUY	$27.43 - $32.7 $75,185 - $89,630	2,741 Added 40.17%	9,564 $280,000
Q1 2021 Apr 14, 2021	SELL	$21.37 - $34.38 $48,937 - $78,730	-2,290 Reduced 25.13%	6,823 $217,000
Q4 2020 Feb 11, 2021	BUY	$15.31 - $21.12 $139,520 - $192,466	9,113 New	9,113 $190,000

254

253M

5.53M

16.5M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.67B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Veriti Management LLC, based on Form 13F filings with the SEC.

Stay updated on Veriti Management LLC with notifications on news.